Loss of Patents Main Cause of Lower Earnings at Eli Lilly and Co (LLY)

The loss of Patents over the years, has been the main cause of lower earnings at Eli Lilly and Co (NYSE:LLY), the CEO of the company, Dr. John Lechleiter, said in an interview on CNBC. The loss of Zyprexa patent in the U.S caused the company the biggest blow as it also resulted in a big fine. The company’s focus now is shifting to investing in R&D as the company continues to look for new opportunities with great potential in the pharmaceutical space.

Eli Lilly & Co. (NYSE:LLY)

“We’ve had several years, starting back in 2011 with our product Zyprexa, which we lost the U.S Patents for late last year and then through this March when we lost Evista. We have had several years where we’ve lost Patents. It has been a roller coaster ride but we settled long, we will continue to invest in R&D,” said Mr. Lechleiter.

Eli Lilly and Co (NYSE:LLY) is now increasing its product pipeline at the back of launching its gastric cancer drug, Cyramza, which has already received FDA approval. The CEO also said that the company is in line to launch other products in the future that should boost its product pipeline. Eli Lilly and Co (NYSE:LLY) expects to resume growth at the end of the year on the back of new product lines according to its CEO.

“We launched Cyramza our drug for advanced gastric cancer a couple of months ago. We have other launches planned, we have other regulatory filings planned, so we are working our way through this period, and we aim with this new product launches to begin to resume growth as we come out of this year,” said  Mr. Lechleiter.

Eli Lilly and Co (NYSE:LLY) will continue to push for research and development in various sectors of medicine, seen as one of the ways that the company can use to discover and develop new products. Partnerships with other small companies with a view of developing products for the mass market also remain a key target for the company according to the CEO.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!